Phase II trial in Europe of PLX PAD in patients with critical limb ischaemia.
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2015
At a glance
- Drugs PLX PAD (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pluristem Therapeutics
- 10 Aug 2015 Positive results from this trial could be sufficient for conditional approval to market PLX cells in this indication according to a Pluristem Therapeutics media release.
- 21 Apr 2015 New trial record